Company profile
AMPEL BioSolutions company profile
AMPEL BioSolutions is a precision medicine company with a pipeline of CLIA-certified gene expression tests for blood or tissue samples that provides decision support by determining disease status, identifying molecular pathways, and predicting drug options. Genomic platforms, bioinformatics, RNA analytics, and ML/AI algorithms are covered by patents and are disease-agnostic. AMPEL BioSolutions was founded to bring personalized precision medicine to patients with immune system and inflammation diseases. In 2022, AMPEL expects to commercialize its first product, a CLIA-certified blood test for lupus patients/physicians called LuGENE that assesses disease state/flares and best drug option(s). AMPEL's technology covers over 95% of all..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://ampelbiosolutions.com
- Contact email
- [email protected]
- Phone number
- 434-296-2675
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2013-07-13
Headquarters
- Headquarters
- Charlottesville, Virginia, United States
- Postal code
- 22902
- Country code
- US
- Continent
- North America